BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31037440)

  • 21. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
    Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
    Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
    [No Abstract]   [Full Text] [Related]  

  • 23. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer.
    Lowder CY; Metkus J; Epstein J; Kozak GM; Lavu H; Yeo CJ; Winter JM
    Ann Surg Oncol; 2018 Dec; 25(13):4004-4011. PubMed ID: 30225835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of lymph node metastasis spread in pancreatic cancer.
    Kanda M; Fujii T; Nagai S; Kodera Y; Kanzaki A; Sahin TT; Hayashi M; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Aug; 40(6):951-5. PubMed ID: 21441841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.
    Oppliger FA; Prakash LR; Newhook TE; Chiang YJ; Ikoma N; Maxwell JE; Kim MP; Vauthey JN; Lee JE; Katz MH; Tzeng CD
    Surg Oncol; 2022 Mar; 40():101673. PubMed ID: 34894620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival.
    Nizri E; Sternbach N; Bar-David S; Ben-Yehuda A; Gerstenhaber F; Ofir T; Wolf I; Weiner G; Lahat G; Klausner J
    Ann Surg Oncol; 2018 Feb; 25(2):475-481. PubMed ID: 29124488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer.
    House MG; Gönen M; Jarnagin WR; D'Angelica M; DeMatteo RP; Fong Y; Brennan MF; Allen PJ
    J Gastrointest Surg; 2007 Nov; 11(11):1549-55. PubMed ID: 17786531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
    Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
    Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
    J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposal of a new lymph node staging system for gastric cancer: study from two institutions in China.
    Zhang J; Jiang K; Liu Y; Ye Y; Lv L; Shen Z; Zhou Y; Wang S
    Med Oncol; 2014 Oct; 31(10):229. PubMed ID: 25213762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic Cancer Lymph Node Resection Revisited: A Novel Calculation of Number of Lymph Nodes Required.
    Arrington AK; Price ET; Golisch K; Riall TS
    J Am Coll Surg; 2019 Apr; 228(4):662-669. PubMed ID: 30677528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic body and tail cancer and favorable metastatic lymph node behavior on the left edge of the aorta.
    Tanaka K; Nakamura T; Asano T; Nakanishi Y; Noji T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
    Pancreatology; 2020 Oct; 20(7):1451-1457. PubMed ID: 32868183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.
    Hoshikawa M; Ogata S; Nishikawa M; Kimura A; Einama T; Noro T; Aosasa S; Hase K; Tsujimoto H; Ueno H; Yamamoto J
    Medicine (Baltimore); 2019 Feb; 98(5):e14369. PubMed ID: 30702628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort.
    Kwon W; He J; Higuchi R; Son D; Lee SY; Kim J; Kim H; Kim SW; Wolfgang CL; Cameron JL; Yamamoto M; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):418-427. PubMed ID: 30118171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.